Trial intelligence / Profile preview

Remimazolam vs midazolam + etomidate for painless ERCP anesthesia in older adults

ChiCTR2100042946Phase 4Recruiting

Sponsor
The Second Hospital of Hebei Medical University
Start
Feb 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam in None (2 arms), sponsored by The Second Hospital of Hebei Medical University. Primary endpoints: Basic vital signs at each observation time point, Operation time, recovery time, VAS pain score, satisfaction, and other recovery-related indicators and 1 more. Started Feb 2021; status: recruiting.

02

Drugs

remimazolam

Beyond the preview

Go deeper on ChiCTR2100042946.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100042946.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call